BREAST PROSTHESIS AND CANCER

Reading time is 2 mins

.
.
BREAST PROSTHESIS AND CANCER

The use of silicone prostheses, which began to be used in America in the 1960s, was suspended in 1992 with the publication of a moratorium and questioned for health risks such as breast cancer, rheumatoid arthritis, fibromyalgia. In the United States, silicone prostheses were released to markets in 2006 and made available again. Articles written in important universities and journals that examined the patient safety of beauty operations stated that silicone implants used in breast augmentation did not cause any health problems until the 2010s.

But in recent years, there has been a risk of developing some form of lymphoma in the naturally occurring capsule around silicone breast implants. This disease, called anaplastic large cell lymphoma (BIA-ALCL) associated with breast prosthesis, is not a cancer of breast tissue, but a type of cancer caused by lymph tissue, and can be seen in all organs, mostly in the skin and lymph nodes.

The first series about the development of ALCL around breast implants began to be published in 2011. The average of 4-8 prosthetic surgery, which can occur years after unilateral breast pain, swelling, asymmetry, stiffness, redness, and rarely is a rare disease that manifests itself in symptoms such as palpable mass: approximately silicone prosthesis in the world exists in more than 20 million by 2021, but according to recent reports, the number of patients a total of 993 in the world, the number of patients who died due to this disease was 36%. The American Society for Plastic Surgery (ASPRS) has announced that women with breast implants in the United States have a 1:30,000 risk of having ALCL during their lifetime.

Anaplastic large cell lymphoma (BIA-ALCL) typically develops around dentures with a rough surface. For this reason, it is necessary to keep ID cards containing information such as manufacturer, brand, model and serial number of your breast implants. Patients using silicone breast implants are also recommended to be examined with a clinical check-up every 6 months for 5 years after surgery, an ultrasound every year and an MRI every 3 years. Anaplastic large cell lymphoma (BIA-ALCL) can be treated by complete removal of the prosthesis and the surrounding capsule.

If there is a constant swelling, pain, stiffness that occurs later in the breast many years after prosthetic surgery, you should definitely consult a Turkish plastic surgery specialist in Turkey.

.
.
.
.

Follow me
President of Organ Transplant Center at MedicalPark Hospital Antalya

Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.

Physician's Resume:

Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.

Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.

In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.

Awards:

Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.

Certificates:

Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .

Professional Members:

American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.

Disclaimer:

Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.
Medically Reviewed by Professor Doctor Alper Demirbaş
Follow me
Latest posts by Medically Reviewed by Professor Doctor Alper Demirbaş (see all)